Article Figures & Data
Tables
Demographic characteristics of case and control subjects
Variables Cases (n = 41) Controls (n = 82) P Value Age (mean) (yr) 65.6 ± 15 68.8 ± 13 .24 Male sex 56.1% (23) 56.1% (46) 1.00 COVID-19 (+) 46.3% (19) 18.3% (15) .001 Diabetes mellitus type 2 48.8% (20) 43.9% (36) .61 Hypertension 73.2% (30) 73.2% (60) 1.00 Coronary artery disease 29.3% (12) 34.1% (28) .59 Congestive heart failure 12.2% (5) 15.9% (13) .59 Dyslipidemia 43.9% (18) 46.3% (38) .80 Atrial fibrillation 29.3% (12) 18.3% (15) .18 Prior stroke 22% (9) 31.7% (26) .26 BMI = 25–29.9 kg/m2 22% (9) 32.9% (27) .21 BMI >30 kg/m2 39% (16) 23.2% (19) .09 Smoking status 34.1% (14) 28.0% (23) .31 Current 12.2% (5) 7.3% (6) .29 Former 22% (9) 20.7% (17) .53 Note:—BMI indicates body mass index.
Jump to section
Related Articles
Cited By...
- SARS-CoV-2 infection of human pluripotent stem cell-derived vascular cells reveals smooth muscle cells as key mediators of vascular pathology during infection
- Association between SARS-CoV-2 and Stroke: Perspectives from a metaumbrella-review
- Evaluation of Stroke Risk Following COVID-19 mRNA Bivalent Vaccines Among U.S. Adults Aged >=65 Years
- Hemorrhagic Transformation Rates following Contrast Media Administration in Patients Hospitalized with Ischemic Stroke
- Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives
- Thromboembolic risk in hospitalised and non-hospitalised Covid-19 patients: A self-controlled case series analysis of a nation-wide cohort
- Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist
- The neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives
- COVID-19 Associated Stroke--A Single Centre Experience